|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
MPN FISH Panel
MessageProbes: PDGFRa, CHIC2, FIP1L1 (4q12) | PDGFRb (5q33) | FGFR1 (8p11) | BCR/ABL1 t(9;22) including ASS1 (9q34) | Probes may be ordered separately.
Disease(s): Myeloproliferative neoplasms
Disease(s): Myeloproliferative neoplasms
Test Code
LAB6069
Alias/See Also
Myeloprofilerative neoplasms
CPT Codes
88374x4 automated. Codes may differ if manual analysis is performed.
Preferred Specimen
•Bone Marrow Aspirate: 1-2 mL sodium heparin tube. EDTA tube is acceptable.
•Peripheral Blood: 2-5 mL sodium heparin tube. EDTA tube is acceptable.
•Fresh, Unfixed Tissue: Tissue in RPMI.
•Fluids: Equal parts RPMI to specimen volume.
•Paraffin Block or Cut Slides: Not available.
•Peripheral Blood: 2-5 mL sodium heparin tube. EDTA tube is acceptable.
•Fresh, Unfixed Tissue: Tissue in RPMI.
•Fluids: Equal parts RPMI to specimen volume.
•Paraffin Block or Cut Slides: Not available.
Instructions
Use cold pack for transport, making sure cold pack is not in direct contact with specimen.
Methodology
FISH
Report Available
3-5 days
Clinical Significance
The MPN FISH panel is indicated in the diagnosis of myeloproliferative neoplasms with eosinophilia and as a guide to therapeutic selection. Patients with BCR-ABL, PDGFRA or PDGFRB rearrangements are responsive to tyrosine kinase inhibitors. There currently is no established TKI therapy for diseases with FGFR1 rearrangement, but some promising new therapies have been reported. If these FISH studies are negative, that does not exclude a myeloproliferative neoplasm and molecular studies for JAK2 and/or MPL mutations should also be considered in the work-up of a possible myeloproliferative neoplasm.
Performing Laboratory
Neogenomics Laboratories